Drug Safety Alerts

NP Thyroid® Tablets Consumer-Level Recall

4/29/2021

On April 29, 2021, Acella Pharmaceuticals, LLC issued a consumer-level recall of NP Thyroid® tablets. This recall was issued because the testing found the affected lots to be sub potent. The products contain less than 90% of the labeled amount of Levothyroxine (T4) or Liothyronine (T3).

This may represent a potential health hazard or safety risk to patients using product affected by this recall.

A complete list of the affected products can be found here.

Acella Pharmaceuticals, LLC advises that patients who are currently taking recalled NP Thyroid® should not discontinue use without contacting their healthcare provider for further guidance and/or a replacement prescription. CVS Caremark is in the process of contacting patients and prescribers to advise them of this recall. We are encouraging patients who are taking NP Thyroid® tablets to contact their prescriber.

CVS Caremark Response: Because of this action, CVS Caremark Mail Service Pharmacy is contacting patients and prescribers to advise them of this recall. We are encouraging patients who are taking NP Thyroid® tablets to contact their prescriber.

For more information about the [action taken], please call Acella Pharmaceuticals, LLC at 470-550-1551, Monday through Thursday, 9:00 AM to 5:00 PM (EST) or Friday, 9:00 AM to 12:30 PM (EST). You may also call the U.S. Food and Drug Administration (FDA) consumer inquiry line at 1-888-INFO-FDA (1-888-463-6332) or visit www.fda.gov.